| The third international consensus definitions for sepsis and septic shock (Sepsis-3) M Singer, CS Deutschman, CW Seymour, M Shankar-Hari, D Annane, ... Jama 315 (8), 801-810, 2016 | 28695 | 2016 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 2000 | 2021 |
| Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit EP Raith, AA Udy, M Bailey, S McGloughlin, C MacIsaac, R Bellomo, ... Jama 317 (3), 290-300, 2017 | 1234 | 2017 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 889* | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 889 | 2020 |
| Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department Y Freund, N Lemachatti, E Krastinova, M Van Laer, YE Claessens, ... Jama 317 (3), 301-308, 2017 | 789 | 2017 |
| Therapeutic anticoagulation with heparin in critically ill patients with Covid-19 EC Goligher, CA Bradbury, BJ McVerry, PR Lawler, JS Berger, MN Gong, ... New England Journal of Medicine 385 (9), 777-789, 2021 | 570 | 2021 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 539 | 2021 |
| Respiratory support in COVID-19 patients, with a focus on resource-limited settings AM Dondorp, M Hayat, D Aryal, A Beane, MJ Schultz The American journal of tropical medicine and hygiene 102 (6), 1191, 2020 | 221 | 2020 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 211 | 2021 |
| Association of the quick sequential (sepsis-related) organ failure assessment (qSOFA) score with excess hospital mortality in adults with suspected infection in low-and middle … KE Rudd, CW Seymour, AR Aluisio, ME Augustin, DS Bagenda, A Beane, ... Jama 319 (21), 2202-2211, 2018 | 206 | 2018 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 122 | 2023 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 106 | 2021 |
| Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ... Jama 327 (13), 1247, 2022 | 98 | 2022 |
| Casemix, management, and mortality of patients receiving emergency neurosurgery for traumatic brain injury in the Global Neurotrauma Outcomes Study: a prospective observational … D Clark, A Joannides, AO Adeleye, AH Bajamal, T Bashford, H Biluts, ... The Lancet Neurology 21 (5), 438-449, 2022 | 88 | 2022 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... Jama 329 (13), 1066-1077, 2023 | 72 | 2023 |
| Simplified prognostic model for critically ill patients in resource limited settings in South Asia R Haniffa, M Mukaka, SB Munasinghe, AP De Silva, KSA Jayasinghe, ... Critical Care 21, 1-8, 2017 | 66 | 2017 |
| Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium … LF Reyes, S Murthy, E Garcia-Gallo, M Irvine, L Merson, I Martin-Loeches, ... ERJ Open Research 8 (1), 2022 | 63 | 2022 |
| Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 C Kartsonaki, JK Baillie, NG Barrio, J Baruch, A Beane, L Blumberg, ... International journal of epidemiology 52 (2), 355-376, 2023 | 60 | 2023 |
| Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial REMAP-CAP Investigators, LPG Derde, AC Gordon, PR Mouncey, ... MedRxiv, 2021.06. 18.21259133, 2021 | 60 | 2021 |
Rashan HaniffaUniversity of Edinburgh, University College Hospital LondonVerified email at ed.ac.uk
